Boston Scientific Corporation
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 4.3B 4.3B 4.0B 3.9B
Cost of revenue 1.3B 1.4B 1.2B 1.2B
Gross profit 3.0B 2.9B 2.7B 2.6B
Operating expense
Research & development 438.1M 448.3M 377.5M 391.2M
Selling general and admin 1.5B 1.5B 1.4B 1.4B
Other operating expenses 10.2M 11.9M 11.9M 7.7M
Operating income 894.9M 803.7M 798.6M 673.3M
Non operating interest income
Income
Expense 74.1M 76.7M 69.9M 68.2M
Other income expense -22.2M 75.9M -41.8M -196.0M
Pretax income 800.3M 802.0M 686.1M 498.6M
Tax provision 156.0M 124.4M 113.3M 19.6M
Net income 643.4M 677.5M 572.7M 479.0M
Basic EPS 0.5 0.5 0.4
Diluted EPS 0.5 0.5 0.4
Basic average shares 1.3B 1.3B 1.3B
Diluted average shares 1.3B 1.3B 1.3B
EBITDA 1.2B 1.3B 1.0B 1.0B
Net income from continuing op. 643.4M 677.5M 572.7M 479.0M
Minority interests 0 1.7M 1.7M 3.4M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 10 minutes

06:49
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).